Adc Therapeutics Ltd (ADCT) Price Prediction & ForecastADCTAdc Therapeutics Ltd

Alphio's ADCT stock price prediction model matches the current Adc Therapeutics Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.53 (-6.24%). The 1-week path is $1.40 (-14.38%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

ADC Therapeutics is currently a hold. The stock is priced at $1.54, significantly below its 52-week high of $4.98, indicating potential for recovery. However, the forward P/E ratio is currently at 0, reflecting uncertainty in future earnings. The recent workforce reduction is expected to save $10 million annually, which could improve financial stability, but the company reported a net income loss of $16.5 million in Q2 2026. The RSI is at 52.051, suggesting the stock is neither overbought nor oversold, indicating a neutral short-term outlook. The main risk is the significant insider selling, which has increased by 1160.65% over the last month, suggesting a lack of confidence from insiders.

Adc Therapeutics Ltd (ADCT) last closed at $1.635, losing -4.94%. These facts feed the 1-day and 1-week ADCT price prediction above.